Publication Details

Pubmed24688049
Title: MCL-1 degradation mediated by JNK activation via MEKK1/TAK1-MKK4 contributes to anticancer activity of new tubulin inhibitor MT189.
Year: 2014
DOI: https://doi.org/10.1158/1535-7163.MCT-13-0629
First Author: Wang
Experimental setup: pull down (Biogrid)
Throughput: Low Throughput (Biogrid)

Interactions

1 interaction
InteractorPartnerSourcesLink
TBA1A_HUMANTBB5_HUMANBioGRIDdetails